YP
GILD icon

Yellowstone Partners’s Gilead Sciences GILD Stock Holding History

Yellowstone Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$447K Buy
6,237
+537
+9% +$40.8K 0.25% 91
2017
Q3 		$462K Buy
+5,700
New +$436K 0.24% 104
2016
Q3 		– Sell
-2,415
Closed -$201K – 252
2016
Q2 		$201K Sell
2,415
-51
-2% -$4.53K 0.09% 182
2016
Q1 		$227K Sell
2,466
-983
-29% -$88.6K 0.1% 170
2015
Q4 		$349K Sell
3,449
-754
-18% -$78.5K 0.16% 114
2015
Q3 		$413K Sell
4,203
-82
-2% -$9.11K 0.2% 92
2015
Q2 		$502K Sell
4,285
-472
-10% -$51.6K 0.23% 76
2015
Q1 		$467K Buy
4,757
+157
+3% +$15.9K 0.24% 86
2014
Q4 		$434K Sell
4,600
-98
-2% -$10.1K 0.23% 89
2014
Q3 		$500K Sell
4,698
-300
-6% -$29.4K 0.28% 68
2014
Q2 		$414K Buy
+4,998
New +$389K 0.24% 84

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Yellowstone Partners's GILD Position: Q4 2017 in Review

Yellowstone Partners increased its Gilead Sciences (GILD) stake by 9.4% in Q4 2017, buying an estimated $40.8K and bringing the position to 6,237 shares worth $447K. The position accounts for 0.25% of the portfolio, ranked #91.

Yellowstone Partners first reported a position in GILD in Q2 2014 and has held it in 11 quarters since. The position peaked at $502K in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Yellowstone Partners held 6,237 shares of Gilead Sciences worth $447K as of Q4 2017.
  • Yellowstone Partners bought 537 Gilead Sciences shares in Q4 2017, an estimated $40.8K.
  • Gilead Sciences made up 0.25% of Yellowstone Partners's portfolio in Q4 2017, its #91 holding.
  • Yellowstone Partners first reported a position in Gilead Sciences in Q2 2014 and has held it in 11 quarters since.
  • Yellowstone Partners's Gilead Sciences position peaked at $502K in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Yellowstone Partners's 13F filing for Q4 2017, filed 24 Jan 2018.